开窗EVAR中渐进式支架释放间序导管置入技术
本文介绍一种用于开窗腔内主动脉修复(FEVAR)的新技术:经肱动脉入路,在渐进式释放主体支架的同时序贯完成靶血管导管置入,以克服经股动脉入路遇到的解剖限制。该技术已成为作者首选的FEVAR方法,但现行FDA批准的开窗支架可能不适用,因为该技术需要支架内预装导丝。
要点
- 经肱动脉入路联合渐进式支架释放,可序贯完成内脏/肾动脉导管置入。
- 该技术旨在克服经股动脉入路在复杂主动脉瘤FEVAR中的解剖限制。
- 现行FDA批准的开窗支架可能不适用,因该技术需支架预装导丝。
核心结论
- 渐进式支架释放间序导管置入技术已成为作者首选的FEVAR方法。
- 该技术可克服经股动脉入路遇到的许多解剖限制。
研究设计与样本
- 本文为技术描述性文章,介绍一种新的FEVAR技术。
主要发现
- 该技术涉及经肱动脉逆行入路,并在靶血管导管置入期间逐步释放支架。
- 即使最有经验的术者,FEVAR中内脏或肾动脉丢失的技术失败风险仍普遍存在。
- 许多解剖条件不佳的患者常因此被拒绝行FEVAR。
临床怎么用
- 该技术可作为经股动脉入路受限的复杂主动脉瘤FEVAR的替代策略。
- 使用前需确认开窗支架是否预装导丝,现行FDA批准支架可能不适用。
局限性
- 现行FDA批准的开窗支架可能不适用于该技术,因其需要预装导丝。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Fenestrated endovascular aneurysm repair (FEVAR) is an alternative to open repair of complex aortic aneurysms. Despite promising short-term results, the technical complexities of this procedure remain a considerable challenge. The risk of technical failure with loss of visceral or renal arteries is ubiquitous even in the most experienced hands, and thus many patients with unfavorable anatomy are frequently denied FEVAR. We have adopted a new technique for FEVAR that involves retrograde brachial artery access and stepwise deployment of the endograft during target vessel catheterization, overcoming many anatomic limitations encountered from a transfemoral approach. This technique, termed sequential catheterization amid progressive endograft deployment, has become our preferred approach for FEVAR and is described in this article. Of note, currently available Food and Drug Administration-approved fenestrated endografts may not be amenable to sequential catheterization amid progressive endograft deployment as this technique requires preloaded wires incorporated into the endografts.
引用
- Timaran CH, Stanley GA, Baig MS, et al. The sequential catheterization amid progressive endograft deployment technique for fenestrated endovascular aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28359720. doi:10.1016/j.jvs.2016.12.139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。